Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment
-
* Corresponding author: Heiner Appel heiner.appel@charite.de
Arthritis Research & Therapy 2008, 10:R125 doi:10.1186/ar2537
Accesses
- Last 30 days: 43 accesses
- Last year: 609 accesses
- All time: 3044 accesses
Cited by
BioMed Central: 2 citations
|
Review
Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis Rik JU Lories, Frank P Luyten, Kurt de Vlam Arthritis Research & Therapy 2009, 11:221 (27 April 2009) This article is part of a collection on Progress in... |
|
Editorial
What do biomarkers tell us about the pathogenesis of ankylosing spondylitis? Walter P Maksymowych Arthritis Research & Therapy 2009, 11:101 (7 January 2009) |